Start Codon’s Post

Need help navigating the complexities of government funding? Get the inside scoop during the Funding Track, sponsored by Leonid Capital Partners, at Fed Supernova, presented by ATI | Advanced Technology International, on August 22. 💰💫 In this track, you'll uncover funding pathways beyond SBIRs, how to transition in post-IPO environments, and more. 👀 Take a seat and learn effective strategies and best practices for harmonizing the relationship between your dual-use technology company and government agencies. Don't miss out — unlock government funding insights at Fed Supernova 🔗 https://hubs.ly/Q02HFfLZ0 #FedSupernova #defenseinnovation #dualuse

In the previous episode, I had an insightful conversation with Torrey Smith regarding Endiatx starting point, the progress it has made so far, and the future prospects that lie ahead. In this episode, I go deeper with Torrey and ask him to share his valuable advice with health tech founders. We also discuss the challenges he faced and the lessons he learned during his journey as a health tech entrepreneur. Therefore, I urge you to stay tuned for an enlightening discussion with Torrey as he shares his wisdom, experiences, and advice with us. Things we discussed navigating the FDA regulations, building a dynamic team, hiring, and thinking big #startup #medtech #healthcare #healthtech#founder #Endiatix #TorreySmith #medicine #stomachcancer #cancer #gastriccancer #GastrointestinalTech #RoboticDiagnostics #robotics #telemedicine #remotediagnostics #medtechinnovation #remotehealthcare #innovation #medicalinnovation Youtube: https://lnkd.in/g-WZQr4j Spotify: https://lnkd.in/gNZV8mZK Apple: https://lnkd.in/gRF2UPQ2

Surge's €7.5M Funding Round: A Boon for Telemedicine & African Healthcare   The successful €7.5 million fundraising by SurgeCare, a European company pioneering immune system decryption for precision medicine, caught my attention. While Surge itself isn't African, its focus on personalized healthcare solutions resonates deeply with Africa's evolving telemedicine and telehealth space.   Here's why this is exciting news: Precision medicine holds immense potential: Tailoring treatments based on individual needs can significantly improve healthcare outcomes, where access to specialized care is limited. Surge's advancements can inspire VC trends: This significant investment by Eurazeo and other partners could encourage more VC interest in telemedicine solutions across Africa, leading to increased innovation and funding. SurgeLab™M and PreCyte® offer promising applications: These innovations focused on acquiring individualized immune signatures and predicting post-operative complications align perfectly with the need for remote diagnostics and personalized care in telemedicine. A bright future for African health: Surge's success story is a testament to the growing importance of personalized healthcare solutions. I'm optimistic that this will pave the way for more telemedicine advancements in Africa, ultimately improving the health and well-being of the continent's population.   Kudos to the SurgeCare team! Their dedication to precision medicine inspires us all. #telemedicine #africa #healthcare #precisionmedicine #venturecapital

Punxsutawney Phil did not see his shadow which means Spring is here just in time for #LSIUSA24 ☀ Since we're just 6 weeks away from the event here's 6 of our most recently announced panels: 1. Corporate VCs: What They Want, and How They Align With M&A and Business Development 2. Accelerating Cardiac Care Innovation: How Can Major Device Companies Collaborate with the Startup Ecosystem? 3. Lab-to-Market: Bridging the Gap Between Academia and Industry 4. Stryker’s Journey to $20B and the Role of M&A 5. The Data-Driven Case for Investing in Diverse Founding Teams 6. The End of One Road and the Beginning of Another: Transition From Pre to Post FDA This is just the beginning. We'll have close to 50 total sessions (panels, fireside chats, keynotes) at the event, so stay tuned as we continue to announce more sessions in the coming weeks. You can also head over to the agenda any time on our website to stay up to date with all of our newest sessions. The event is approaching capacity, so secure your spot today while we're still accepting registrations. See you in Dana Point! #fridaymeme

Great news! Valerie Daggett, our CEO is nominated for Geekwire's Startup CEO of the Year! The winner is selected by community vote - so show your support by clicking on the link below and voting! Also check out the link below to The Long Run podcast by Luke Timmerman and hear more about Valerie and AltPep! #geekwireawards #alzheimersdisease

What if there were a way to transform the care of brain injury patients? FONGIT-supported startup ABCDx SA believes that its biomarker panels and expertise hold the potential to do just that. Watch the video below to find out how they are working to democratize brain diagnostics and significantly improve clinical outcomes for patients ⤵ ⤵ #HealthcareInnovation #BrainInjury #ClinicalOutcomes

When thinking about this "second Wave of Innovation" that we keep talking about- both stratfi and APFIT play a huge role. learn more about both in this blog: APFIT and STRATFI/TACFI: Two Different Paths Over the Valley of Death - Long Capture https://hubs.la/Q02sVtHl0

It’s hard to believe that such things happen and that’s why it’s so important that we get educated on investing and creating passive income! Learn more The Doctor Investor and check out our latest offering the Medinvest Income Fund, which offers 10% annualized returns, tax deferred! Click on the link below: https://lnkd.in/gJpBiFWw #passiveincome #doctor #medicaljourney #realestateinvesting

We’re thrilled to co-lead Power's $12M Series A, alongside our friends Nikhil Basu Trivedi at Footwork and Kin Ventures. Patient recruitment is a massive bottleneck in clinical trials. 86% of U.S. trials are delayed due to lack of enrollment. Yet <5% of American patients participate in potentially life-changing trials. Many must advocate for themselves, wrestling with dense jargon, unclear tradeoffs, and an opaque enrollment process. Power is reimagining trial recruitment starting with a patient-led marketplace. Therapeutic options should be easily accessible for everyone — regardless of geographical location, ethnicity, or socioeconomic background. Unlocking access for patients is only act one. We believe Power has the potential to redefine how patients, researchers, and life science partners interact in the clinical trial system.

First up on our trip down memory lane, Curative, takes us back to 2020, pandemic in full swing. Curative is a biomedical startup that was able to pivot to create the mouth-swab testing alternative to test for COVID-19 – compared to the intrusive nasal swab testing format. They quickly got contracts, but needed to create a backend to their website capable of managing the entire supply chain for the Department of Defense. Check out the case study to learn more! https://hubs.ly/Q02yRVxZ0 #eCommerce #RapidDeployment #summersolutionshowcase